logo

For the Inventor, By the Inventor

Stamford, CT, United States of America

Springworks Therapeutics, Inc.


USPTO Granted Patents = 49


Forward Citations = 99

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Kristin Patterson (29 out of 30 patents)

silverMedal Todd Shearer (26 out of 26 patents)

bronzeMedal Uchenna H Iloeje (15 out of 15 patents)

4.  Abraham J Langseth (15 out of 15 patents)

5.  Rex Williams (12 out of 12 patents)

6.  Shinta Cheng (12 out of 12 patents)

7.  Allison Lim (12 out of 12 patents)

8.  Jiping Liu (9 out of 9 patents)

9.  Mark Hatcher (9 out of 10 patents)

10.  Arnaud Marchand (5 out of 22 patents)

11.  Bart Vanderhoydonck (5 out of 15 patents)

12.  Matthias Versele (5 out of 5 patents)

13.  Aurélie Candi (5 out of 5 patents)

14.  Ricky Wayne Couch (4 out of 11 patents)

15.  Peter Gregory Varlashkin (4 out of 4 patents)


Core Competencies:
Mirdametinib
Nirogacestat
YAP/TAZ-TEAD Inhibitors
Plexiform Neurofibromas
Combination Therapy
Anti BCMA Antibody
Pharmaceutical Compositions
Dosage Forms
Chlorinated Tetralin Compounds
Fluorinated Phenylamino Compounds
2-Pyrazole Anilines
Tetrahydropyridopyrimidines

49 patents:

1. 12673950 - Spiros and related analogs for inhibiting YAP/TAZ-TEAD (2026-07-07),
2. 12667560 - Co-administration of mirdametinib and lifirafenib for use in treating cancers (2026-06-30),
3. 12667555 - Treatment of ovarian cancer with nirogacestat (2026-06-30),
4. 12661330 - Mirdametinib treatment (2026-06-23),
5. 12599587 - Chlorinated tetralin compounds and pharmaceutical compositions (2026-04-14),
6. 12570752 - COMBINATION THERAPY WITH AN ANTI BCMA ANTIBODY AND A GAMMA SECRETASE INHIBITOR (2026-03-10),
7. 12552772 - 2-pyrazole anilines and related analogs for inhibiting YAP/TAZ-TEAD (2026-02-17),
8. 12516064 - Tetrahydropyridopyrimidines and related analogs for inhibiting YAP/TAZ-TEAD (2026-01-06),
9. 12390430 - Mirdametinib treatment (2025-08-19),
10. 12383517 - Dosage forms of mirdametinib (2025-08-12),
11. 12378202 - Tetrahydrobenzoazepinones and related analogs for inhibiting YAP/TAZ-TEAD (2025-08-05),
12. 12357597 - Dispersible formulations of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benazmide and uses thereof (2025-07-15),
13. 12324791 - Mirdametinib treatment (2025-06-10),
14. 12295925 - Treatment of neurofibromatosis type 1 (NF1) associated plexiform neurofibromas (PN) in pediatric patients with mirdametinib (2025-05-13),
15. 12275688 - Crystalline solids of MEK inhibitor N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof (2025-04-14),
Company Overview
Springworks Therapeutics, Inc. is a biopharmaceutical company based in Stamford, CT, focused on developing innovative therapies for underserved patient populations. The company specializes in treatments for Neurofibromatosis Type 1, particularly targeting plexiform neurofibromas through its lead compounds, Mirdametinib and Nirogacestat. Springworks is advancing research in YAP/TAZ-TEAD inhibition and is committed to creating dispersible formulations and crystalline solids to enhance drug delivery and efficacy, employing non-linear dosing strategies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

49 Patents

#23 in Stamford, CT

#190 in Connecticut

#7,138 in US

#14,266 in the World

Stamford, CT (US)
Stamford, CT, United States of America

Springworks Therapeutics, Inc.

Forward Citations = 99

25 inventors:

goldMedal Kristin Patterson (29 out of 30 patents)

silverMedal Todd Shearer (26 out of 26 patents)

bronzeMedal Uchenna H Iloeje (15 out of 15 patents)

4.  Abraham J Langseth (15 out of 15 patents)

5.  Rex Williams (12 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Springworks Therapeutics, Inc.. Retrieved from https://idiyas.com/company/springworks-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Please report any incorrect information to [email protected]
Loading…